NCT05945862 (NUTRIGANDO) is a NA clinical trial of NUTRIGANDO in Cardiovascular Diseases, sponsored by Instituto Tecnologico de Sonora.

Who is sponsoring NCT05945862?

NCT05945862 is sponsored by Instituto Tecnologico de Sonora.

What drugs are being tested in NCT05945862?

Interventions in NCT05945862: NUTRIGANDO.

What condition does NCT05945862 study?

NCT05945862 studies Cardiovascular Diseases, Diabetes Mellitus, Type 2.

Is NCT05945862 still recruiting?

NCT05945862 is currently completed. Last updated 23 March 2026.

Last reviewed 2026-03-23 · How we verify

NCT05945862: NUTRIGANDO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Healthy Lifestyle Promotion Program in Communities From the Yaqui Valley

Completed NA Last updated 23 March 2026

What this trial tests

NA trial testing NUTRIGANDO in Cardiovascular Diseases in 50 participants. Completed in 31 December 2025.

Timeline

17 July 2023

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Instituto Tecnologico de Sonora
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	50
Start date	17 July 2023
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across Mexico

Drugs / interventions tested

NUTRIGANDO

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Instituto Tecnologico de Sonora

Who can join

Adults 7 to 60, any sex, with Cardiovascular Diseases or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to evaluate the change in indicators of lifestyle and its effect on cardiometabolic biomarkers as a response to an integrative mother-child intervention to promote healthy lifestyles and prevent food insecurity and child malnutrition in vulnerable communities in the Yaqui Valley, Sonora, Mexico. The intervention consists in a program including nutrition education and physical activity training, with a total duration of 6 months. The proposal addresses the problem in an integrative and non-conventional way, generating new multifactorial knowledge of cardiometabolic and behavioral markers, and their relationship with each other, helping to reduce family food insecurity and improving lifestyle and health, and to support vulnerable families in achieving social justice in the field of nutrition.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comprehensive Intervention to Promote Healthy Lifestyles and Prevent Cardiometabolic Diseases in Low-Income School Children From Mexico: Protocol for the ESCOLARISANO Randomized Controlled Trial.
Escárcega-Galaz AA, Enriquez-Rabago E, Garcia-Moreno M, Leyva-Encinas S, et al · · 2026 · PMID 42090578 · DOI 10.2196/82721

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05945862 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Tecnologico de Sonora
Last refreshed: 23 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05945862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing